Medicine for curing angiocardiopathy and its preparation method
A cardiovascular and worm technology, which is applied in the field of worm drugs for treating cardiovascular diseases and its preparation, can solve the problems of not using 5 kinds of worms at the same time to treat cardiovascular diseases and the effect of drug effects, and achieves improvement of blood rheology, Guaranteed drug efficacy and thrombolytic effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] After 2kg of cleaned scorpions, 0.5kg of centipedes, 1.5kg of earthworms, 1.5kg of ground beetles and 1.5kg of leeches were mixed in proportion, they were ground and homogenized with a colloid mill. Then collect the ground slurry and squeeze it with a filter press to separate the filter residue from the filtrate. The filtrate is dried by a vacuum freeze dryer to prepare a dry powder. After the filter residue is decalcified, protein removed, and bleached to extract chitin, it is then Digestion, drying and other processes are prepared into chitosan. After the dry powder and the chitosan are respectively pulverized, mixed, thoroughly mixed, and packaged, 2.16 kg of the medicine of the present invention are obtained.
Embodiment 2
[0040] After cleaning 15kg scorpion, 10kg centipede, 20kg earthworm, 20kg ground beetle and 25kg leech are mixed in proportion, grind and homogenate with colloid mill. Then the ground slurry is collected and squeezed by a filter press to separate the filter residue from the filtrate, and the filtrate is dried by a vacuum freeze dryer to prepare a dry powder, and chitin is extracted from the filter residue to prepare chitosan. After the dry powder and the chitosan are pulverized respectively, mixed, thoroughly mixed, and packaged, 28.96 kg of the medicine of the present invention are obtained.
Embodiment 3
[0042] Influence of the medicine of the present invention on the blood biochemical indexes of dogs with experimental myocardial ischemic infarction
[0043] Adopt ligation of coronary artery to cause canine acute myocardial ischemia model, then infuse the drug of the present invention through duodenum, intubate to coronary venous sinus through external jugular vein, measure the effect of different experimental time points before ligation of coronary artery medicine and after medicine. Serum creatine phosphokinase (CPK), serum lactate dehydrogenase (LDH) and plasma endothelin (ET). The experimental results show that, compared with the control group, the worm medicine can significantly inhibit the increase of CPK activity caused by myocardial ischemia and myocardial infarction (P<0.01), can reduce the content of ET (P<0.05), and has an inhibitory effect on LDH (P<0.05). It is confirmed that the worm medicine has inhibitory effect on experimental acute myocardial ischemia and ac...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com